JFA
ALIM

JNBA Financial Advisors’s Alimera Sciences ALIM Stock Holding History

JNBA Financial Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-94
Closed -$2K – 1410
2016
Q3 		$2K Buy
+94
New +$2.16K ﹤0.01% 1454

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

JNBA Financial Advisors's ALIM Position: Q4 2016 in Review

JNBA Financial Advisors sold out of Alimera Sciences (ALIM) in Q4 2016, closing a stake of 94 shares — an estimated $2K sold.

JNBA Financial Advisors first reported a position in ALIM in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • JNBA Financial Advisors reported no remaining Alimera Sciences position as of Q4 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 94 Alimera Sciences shares in Q4 2016, an estimated $2K.
  • JNBA Financial Advisors first reported a position in Alimera Sciences in Q3 2016 and held it in 1 quarter.
  • JNBA Financial Advisors's Alimera Sciences position peaked at $2K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on JNBA Financial Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.